Aigen Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Buy |
+8,298
| New | +$328K | 0.04% | 500 |
|
|
2025
Q1 | – | Sell |
-17,723
| Closed | -$620K | – | 882 |
|
|
2024
Q4 | $620K | Buy |
17,723
+6,111
| +53% | +$214K | 0.11% | 272 |
|
|
2024
Q3 | $465K | Buy |
+11,612
| New | +$465K | 0.09% | 343 |
|
|
2024
Q2 | – | Sell |
-16,747
| Closed | -$726K | – | 897 |
|
|
2024
Q1 | $726K | Sell |
16,747
-56,973
| -77% | -$2.47M | 0.16% | 197 |
|
|
2023
Q4 | $3.73M | Buy |
+73,720
| New | +$3.73M | 0.67% | 17 |
|
|
2023
Q3 | – | Sell |
-16,019
| Closed | -$657K | – | 950 |
|
|
2023
Q2 | $657K | Buy |
+16,019
| New | +$657K | 0.1% | 285 |
|
|
2021
Q3 | – | Sell |
-8,912
| Closed | -$355K | – | 559 |
|
|
2021
Q2 | $355K | Buy |
+8,912
| New | +$355K | 0.06% | 291 |
|
|
2021
Q1 | – | Sell |
-42,747
| Closed | -$2.42M | – | 754 |
|
|
2020
Q4 | $2.42M | Buy |
42,747
+36,349
| +568% | +$2.06M | 0.32% | 71 |
|
|
2020
Q3 | $304K | Sell |
6,398
-16,367
| -72% | -$778K | 0.04% | 535 |
|
|
2020
Q2 | $1.34M | Sell |
22,765
-12,489
| -35% | -$736K | 0.17% | 174 |
|
|
2020
Q1 | $1.67M | Buy |
35,254
+24,199
| +219% | +$1.14M | 0.22% | 116 |
|
|
2019
Q4 | $668K | Buy |
+11,055
| New | +$668K | 0.11% | 264 |
|